GPX4 and neoplasm: Previous studies showed that inhibiting GPX4 results in T cell activation in mouse models of colorectal cancer; However, tumor cells subsequently overexpress PD-L1 and there was an increase in myeloid-derived suppressor cells (MDSCs) in the immune microenvironment, which impaired the cytotoxic activity of these T cells against tumor cells 17.